As healthcare costs soar, the Congressional Budget Office (CBO) has recently shed light on a hot political issue: the ...

In a recent court filing, Teva Pharmaceuticals USA, Inc., and Teva Neuroscience, Inc. (collectively, Teva), noted that active ...

Owners of a wholesale drug distributor were recently indicted in the Southern District of Florida for alleged engagement in a scheme involving counterfeit HIV drugs. Adam Brosius, Patrick Boyd, and ...

In a recent global compliance presentation at the Informaconnect, Aggregate Spend and HCP Engagement, Elon Shelf, Senior ...

In today's healthcare environment, physicians face numerous challenges that significantly impact their professional lives and ...

Office of Prescription Drug Promotion (OPDP) recently sent an Untitled Letter to AbbVie, Inc., regarding a television ad starring Serena Williams for its migraine medicine Ubrelvy. According to the ...

On June 28, 2024, the Supreme Court rejected the doctrine of Chevron deference in the closely watched case of Loper Bright Enterprises v. Raimondo. In a 6-3 decision, the Court held that Chevron’s rul ...

The United States Department of Justice (DOJ) and National Interventional Radiology Partners (NIRP) recently announced an $8.8 million settlement that resolves allegations that the company violated th ...

James Comer, Chairman of the United States House Committee on Oversight and Accountability, called on CEOs of three pharmacy benefit managers (PBMs) to correct the record for statements made during th ...

In the ongoing battle against antibiotic-resistant infections, continuous education and adaptation of new strategies are crucial. This October, healthcare professionals specializing in infectious dise ...